 Home > Active Ingredient News > Drugs Articles > Forbes' "30 under 30" list is out, what changes are these young talents expected to bring to the healthcare field?

Forbes' "30 under 30" list is out, what changes are these young talents expected to bring to the healthcare field?

 Last Update: 2023-01-01
 Source: Internet
 Author: User

Tags

total change

what spf 15

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 29, Forbes magazine announced its annual "30 under.
" 30" list
.
Among them, the list of health care is from 30 startups and scientific research institutions, including founders and CEOs of startups, as well as scientists, aged 23-29
.
In this article, let's take a look at how the companies of these outstanding young people are revolutionizing the healthcare system.

Dr.
Dina Radenkovic, 27 years old

Co-founder and Chief Executive Officer (CEO) of Gameto

Image source: Gameto's official website

Dina Dr.
Radenkovic is the co-founder and CEO
of Gameto.
Founded in 2021, Gameto's goal is to synchronize the pace of ovarian aging with the aging rate of other organs by developing an ovarian treatment platform
.
Gameto's philosophy is to reshape the ovaries through science, and the company's research efforts include remodeling the development and function of the ovaries in vitro, understanding the intrinsic growth factors and genetic networks
that drive human ovarian development and egg production.
Some of the initial studies conducted at Harvard Medical School showed that Gameto made a breakthrough in solving the problem of accelerating ovarian aging, generating the first human ovarian reprogramming cells (granule cells and oocytes precursors).

The first human ovarian reprogramming cells (granule cells and oocytes precursors) were generated by developing an ovarian treatment platform that synchronizes the pace of ovarian aging with the aging rate of other organs

Dr.
Amira Barkal, 29 years old

Co-founder of Pheast Therapeutics

Image source: LinkedIn

Amira Dr.
Barkal is a co-founder
of Pheast Corporation.
Founded in 2020, Pheast focuses on cancer immunotherapy
.
The company's development strategy is focused on enhancing innate immune responses by targeting macrophage immune checkpoint proteins that prevent macrophages from engulfing tumor cells, what we commonly call "don't eat me" signals
.
One of Pheast's research and development goals is to develop CD24-targeted therapies
for ovarian, breast and other solid tumors targeting the CD24 signaling pathway.
In April 2022, Pheast completed a $76 million Series A financing
.

The company's development strategy is focused on enhancing innate immune responses by targeting macrophage immune checkpoint proteins, and one of Pheast's research and development goals is to develop CD24-targeted therapies for ovarian, breast and other solid tumors targeting the CD24 signaling pathway

Dr.
Aadil Ali, 29 years old

Clinical scientist at Traferox Technologies

Dr.
Aadil Ali is a clinical scientist
at Traferox.
Traferox is a medical device company
.
Lung transplantation requires keeping organs in optimal condition to ensure surgical success
.
Aadil Dr.
Ali's research helped Traferox develop a new organ transplant device that broadened the time window
for transplantation.

Dr.
Alison Burklund, 28 years old

Co-founder and CTO of Nanopath

Image source: Nanopath's official website

Alison Burklund is the co-founder and CTO
of Nanopath.
Founded in 2019, Nanopath is a molecular diagnostics company
looking to disrupt traditional testing methods.
According to Nanopath's official website, through biosensing technology, the company has the potential to perform rapid and highly complex inspections
in minutes.
In August 2022, the company announced the completion of a $10 million Series A funding round that will be used to develop and commercialize its biosensing platform to transform the way
pelvic and gynecologic infections are diagnosed in women.

is a molecular diagnostics company looking to disrupt traditional testing methods for the development and commercialization of its biosensing platform to transform the way pelvic and gynecologic infections are diagnosed in women

Mr.
Jared Dauman, 27 years old

Co-founder of Soda Health

Image source: Soda Health's official website

Mr.
Jared Dauman is the co-founder
of Soda Health.
Soda Health is a healthcare technology company focused on building solutions to eliminate health inequalities
.
The company aims to remove healthcare barriers
by connecting payers, members, and retailers.
In September 2022, the company announced a $25 million Series A funding round
.

Mr.
Mack Mazeski, 29 years old

Mr.
Owen Prunskis, 29 years old

Founding team member of DxTx Pain and Spine

Image source: DxTx Pain and Spine official website

Mr.
Mack Mazeski and Mr.
Owen Prunskis were members of the founding team of
DxTx Pain and Spine.
DxTx Pain and Spine was founded to help pain and spine surgery centers reduce the need
for opioid use and surgery by better treating back problems.
The company has partnered with more than 60 vendors and serves
approximately 200,000 patients annually.
To date, the company has raised $36 million
.

To help pain and spine surgery centers reduce the need for opioid use and surgery by better treating back problems

Ahmed Elsayyad, 29

Co-founder of Ostro

Ahmed Elsayyad is the co-founder
of Ostro.
Ostro partners with pharmaceutical companies to connect
consumers directly with doctors through customized apps and websites.
AstraZeneca and Bausch Health is a customer of
the company.
The company has raised $56 million in funding from investors including Founders Fund, Greycroft and Bling Capital
.

Mr.
Elliot Fisher, 28 years old

Co-founder of Curi Bio

Image source: Curi Bio's official website

Mr.
Elliot Fisher is the co-founder
of Curi Bio.
Curi Bio aims to use stem cell technology to develop organ-on-a-chip models of human heart and muscle tissue to test new drugs, and has built an AI-based data analysis platform
.
The company's goal is to reduce animal testing and use safer drugs
.
Curi Bio has raised $20 million
from investors, including Dynamk Capital.

It aims to use stem cell technology to develop organ-on-a-chip models of human heart and muscle tissue to test new drugs

Mr.
Ed Gaussen, 28 years old

Co-founder of Mantra Health

Credit: LinkedIn Mr.
Gaussen is Mantra Co-founder
of Health.
The latter is a remote psychological diagnosis and treatment platform that mainly provides mental health care services
for college students.
Currently, more than 100 universities and 800,000 students use Mantra Health, including MIT, Cornell University, Pennsylvania State University, and more
.
Since inception, Mantra Health has completed a total of $27.
7 million in financing
.

Mr.
Peeyush Shrivastava, 26 years old

Mr.
Vineet Erasala, 26 years old

Mr.
Emmanuel Setegn, 26 years old

Co-founder of Genetesis

Image source: Genetesis official website

Mr.
Peeyush Shrivastava, Mr.
Vineet Erasala and Emmanuel Mr.
Setegn is a co-founder
of Genetesis.
Genetesis focuses on developing biomagnetic imaging tools that help doctors measure the heart's magnetic field and diagnose heart problems
.
Since its inception in 2017, the company has raised a total of $40 million
.

Ms.
Giovanna Abramo, 29 years old

Co-founder of Plenna Corporation

Giovanna Ms.
Abramo is the co-founder
of Plenna.
Plenna, a women's health technology platform serving patients in Latin America, aims to reduce barriers that prevent women from accessing sexual/reproductive health treatment by connecting them with doctors for in-person and online
consultations.

Ms.
Jessica Chao, 29 years old

Co-founder of LingoHealth

Image source: LingoHealth's official website

Jessica Ms.
Chao's co-founder, LingoHealth, has a digital health platform that helps older patients and their caregivers navigate
their health in their preferred language.
The company's target demographic is 20 percent of Americans who speak a language
other than English at home.
Currently, LingoHealth has raised $1 million in funding
.

Mr.
Jake Cooper, 28 years old

Mr.
Manoj Kanagaraj, 28 years old

Co-founder of Grow Therapy

Image source: LinkedIn

Mr.
Manoj Kanagara and Mr.
Jake Cooper are co-founders
of Grow Therapy.
Grow Therapy is an online therapy platform that connects patients with
doctors.
Currently, the company has worked with approximately 100,000 patients and 3,000 clinicians and secured $85 million in financing
.

Dr.
Shu Jiang, 29 years old

Assistant Professor, Washington University School of Medicine, St.
Louis

Image source: Washington University School of Medicine in St.
Louis website

Shu Dr.
Jiang's research focuses on developing statistical methods
for precision oncology in the field of breast cancer.
She is working to improve breast cancer risk prevention, including addressing racial disparities in healthcare and optimizing risk prevention models to include women
of different ethnicities.

Mr.
Cavan Klinsky, 26 years old

Co-founder of Healthie

Image source: LinkedIn

Cavan Healthie, a company co-founded by Mr.
Klinsky, has developed a remote health and practice management platform that millions of organizations and patients can use
in chronic pain, cardiac rehabilitation, addiction treatment, weight loss, and more.
Currently, the company has received $18 million in venture capital
.

Mr.
Landolina, 29 years old

Co-founder of Cresilon

Image source: Cresilon's official website

Mr.
Landolina is the co-founder
of Cresilon.
THE LATTER, A BIOTECHNOLOGY COMPANY, HAS DEVELOPED A SINGLE-USE PLANT GEL VETIGEL THAT QUICKLY STOPS BLEEDING AND HAS BEEN APPROVED FOR VETERINARY USE
IN THE UNITED STATES, THE UNITED KINGDOM AND CANADA.
THE COMPANY IS ALSO WORKING TO OBTAIN HUMAN USE CLEARANCE
FROM THE U.
S.
FDA FOR VETTIGEL.
Cresilon has raised nearly $82 million
.

Mr.
Alfredo Andere, 24 years old

Mr.
Kyle Giffin, 24 years old

Mr.
Kenny Workman, 23 years old

Co-founder of Latch Bio

Image source: Transcend Therapeutics website

To bridge the gap between scientists and software engineers and enable them to store and analyze large amounts of data together, Mr.
Alfredo Andere, Mr.
Kyle Giffin and Kenny Mr.
Workman co-founded Latch Bio, Inc.
, where they serve as CEO, COO and CTO
.
Latch Bio is building a web-based platform that enables any biologist to analyze research data
.
Since its inception in February 2021, the company has raised more than $33 million in cumulative financing
.

Latch Bio is building a web-based platform that enables any biologist to analyze research data
.

Mr.
Vincent Lopez, 28 years old

Founder and CEO of Parker Health

Image source: Parker Health's official website

Mr.
Vincent Lopez is a biotechnology company Parker Founder and CEO
of Health.
He also developed a cloud platform called ParkerSuite that can be used to improve interoperability
between programs used by healthcare providers.
Parker Health's customers include Microsoft and Google and has received $2.
5 million in venture capital support
.

A cloud platform that can be used to improve interoperability
between programs used by healthcare providers.

Mr.
Blake Mandell, 28 years old

Co-founder of Transcend Therapeutics

Image source: Transcend Therapeutics website

Mr.
Blake Mandell co-founded Transcend Therapeutics, a biotechnology company that develops neuropsychiatric therapeutics
.
The company is working toward FDA approval for its main drug candidate, TSND-201
.
The drug is being studied in patients with depression or post-traumatic stress disorder (PTSD) and has been shown to benefit
more than 80% of patients in clinical studies.

People with depression or post-traumatic stress disorder (PTSD).

Mr.
Niema Moshiri, 29 years old

Assistant Professor of Instruction, University of California, San Diego

Image source: LinkedIn

Mr.
Niema Moshiri is a student of the University of California San Diego Diego).

After the COVID-19 pandemic began, he developed a suite of bioinformatics tools to help researchers quickly process SARS-CoV-2 sequencing data, which enabled scientists to study the origin and spread
of COVID-19.

Dr.
Briana Chen, 24 years old

Postdoctoral researcher at Columbia University

Image source: LinkedIn

Dr.
Briana Chen is a graduate of Columbia University Postdoctoral researcher at the University with a focus on gender differences
in the field of mental health.
Her research found that women are twice as likely as men to suffer from depression, but tend to have some different symptoms
.
Hence, Briana Chen is working on an antidepressant
for women.

Antidepressants for women

Mr.
TJ Ademiluyi, 27 years old

Co-founder of Alaffia Health

Image source: LinkedIn

Mr.
TJ Ademiluyi is Alaffia Co-founder
of Health.
The latter, which is using artificial intelligence to help patients avoid accepting erroneous medical bills, currently has more than 300,000 members
.
The company said it expects to save customers $15 million
by the end of the year.

Mr.
Kevin Parker, 28 years old

Co-founder of Cartography Biosciences

Image source: LinkedIn

Mr.
Kevin Parker is Cartography Co-founder
of Biosciences.
The latter is developing effective methods to analyze the immune system using molecular and computational tools and redirect the patient's immune system to treat cancer
.
The company currently has a team of 33 people and has raised $57 million in funding
.

and redirect the patient's immune system to treat the cancer

Mr.
Nikhil Patel, 23 years old

Founder of Craniometrix

Image source: LinkedIn

Nikhil Mr.
Patel is the founder of
Craniometrix.
The latter is developing a simple-to-use Alzheimer's disease diagnostic method that can be performed on
a smartphone.
Craniometrix has raised more than $6 million in funding
.

Mr.
Jonah Kallenbach, 27 years old

Mr.
Ankit Gupta, 27 years old

Co-founder of Reverie Labs

Image source: Reverie Labs website

Mr.
Jonah Kallenbach and Mr.
Ankit Gupta co-founded Reverie, a drug development platform Labs, which aims to develop a new generation of drugs to better treat deadly brain cancer
.
Since its inception in 2017, Reverie Labs has raised a total of $32.
1 million in financing
.
In addition, the company has signed a collaboration agreement with Roche and its subsidiary Genentech to leverage Reverie's unique technology platform to virtually screen multiple kinase inhibitor discovery programs to advance drug discovery
.

Ms.
Saumya Sao, 24 years old

Co-founder of the Johns Hopkins Medical Group Violet Project

Image source: Violet Project official website

Saumya Ms.
Sao and her partners co-founded the non-profit Violet project
.
It is a digital health platform that aims to provide adolescents with reliable, comprehensive and easy-to-understand sexual/reproductive health education and related health kits
.
The Violet project also connects
its clients who test positive for STIs (or sexually transmitted diseases) with doctors who can provide appropriate treatment.

Mr.
Gregory Sepich-Poore, 29 years old

Co-founder of Micronoma

Image source: Micronoma's official website

Mr.
Sepich-Poore's research found that no human cancer is sterile and that microbes can reveal the type and presence of cancer, making it easy to detect
at an early stage.
With that in mind, Micronoma, a company he co-founded, is developing a microbiome-based diagnostic that can detect cancer
early.
The company has raised $17.
5 million in funding
.

A microbiome-based diagnostic method is being developed that could detect cancer early

Ms.
Katie-Rose Skelly, 29 years old

Co-founder of Known Medicine

Image source: Known Medicine's website

According to a press release from Forbes, only 3.
4% of oncology drugs enter the market in clinical trials, and only 50% of advanced cancer patients benefit
from their first treatment.
To change that number, Katie-Rose Ms.
Skelly co-founded Known Medicine, a company that hopes to use machine learning to predict the response rate and prognosis
of patients using new drugs.
And that idea has made Known Medicine raised $7.
2 million in seed funding
.

It is hoped that machine learning will predict the response rate and prognosis of patients using new drugs

Dr.
Felix Wong, 29 years old

Co-founder and CEO of Integrated Biosciences

Image source: Integrated's official website

Dr.
Felix Wong is a postdoctoral fellow at MIT and is also Integrated Co-founder and CEO
of Biosciences.
Integrated aims to control cellular stress responses
for next-generation therapies by combining synthetic biology and machine learning.
The company has developed a platform to help identify potential drug targets by analyzing cellular stress
responses.
At MIT, Felix Dr.
Wong's research focuses on discovering life-saving drugs, especially antibiotics
, that can fight drug-resistant bacterial infections.

The aim is to control the cellular stress response of next-generation therapies by combining synthetic biology and machine learning

Ms.
Joan Zhang, 27 years old

Co-founder of Arise

Image source: LinkedIn

Nearly one in ten people will experience an eating disorder in their lifetime, but not all will get the help
they need.
This is Joan The problem Zhang and her company, Arise, want to solve, and the company wants to change that and provide support
that applies to real life.
Arise hopes to improve access to eating disorder treatment through virtual care pathways, community support
, and more.

Arise hopes to improve access to eating disorder treatment through virtual care pathways, community support, and more

Original: _mstmutation="1" _msthash="220780" _msttexthash="11953110">

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.